C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2011
12/22/2011	WO2011094584A3 Method and system for purifying and quantitating proteins using heme fusion tags
12/22/2011	WO2011091324A3 Methods of generating zinc finger nucleases having altered activity
12/22/2011	WO2011082381A3 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages
12/22/2011	WO2011081421A3 Complement c9 as markers for the diagnosis of cancer
12/22/2011	WO2011072276A3 Cell lines from the black witch moth ascalapha odorata
12/22/2011	WO2011071982A3 Synthesis of prazole compounds
12/22/2011	WO2011068341A3 Gene and protein for biosynthesis of tricyclocompounds
12/22/2011	WO2011066458A3 Novel genomic biomarkers for irritable bowel syndrome diagnosis
12/22/2011	WO2011051486A3 Pharmaceutical solution of non covalently bound albumin and acylated insulin
12/22/2011	WO2011011796A8 Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels
12/22/2011	WO2010111891A8 Modified oligo-nucleic acid molecule, preparation method and uses thereof
12/22/2011	WO2008068638A8 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
12/22/2011	US20110314575 Plasmodium Vaccines, Antigens, Compositions and Methods
12/22/2011	US20110314573 Screening method for identifying genes involved in plant cell cycle
12/22/2011	US20110314572 Cotton plant with seed-specific reduction in gossypol
12/22/2011	US20110314571 Method to trigger rna interference
12/22/2011	US20110314570 Drought tolerant plants and related constructs and methods involving genes encoding zinc-finger (c3hc4-type ring finger) family polypeptides
12/22/2011	US20110314569 Combination of Two Genetic Elements for Controlling the Floral Development of a Dicotyledonous Plant, and Use in Detection and Selection Methods
12/22/2011	US20110314568 Soybean Cultivar S090069
12/22/2011	US20110314567 Soybean Cultivar S090057
12/22/2011	US20110314566 Soybean Cultivar S090086
12/22/2011	US20110314565 Method for Isolating Cell-Type Specific mRNAS
12/22/2011	US20110314564 Enzymes and methods for hydrolysing phenylureas, carbamates and organophosphates
12/22/2011	US20110313135 Recombinant Monovalent Antibodies
12/22/2011	US20110313133 Albumin variants and conjugates
12/22/2011	US20110313045 Histone deacetylases, and uses related thereto
12/22/2011	US20110313029 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
12/22/2011	US20110313028 Suppressor of ap-1
12/22/2011	US20110313027 Methods and substances for stimulating muscle regeneration
12/22/2011	US20110313026 Dna and proteins or peptides specific of bacteria of the neisseria meningitidis species, methods for obtaining them and biological applications thereof
12/22/2011	US20110313025 Methods and compositions involving mirna and mirna inhibitor molecules
12/22/2011	US20110313023 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF
12/22/2011	US20110313018 Cancer related gene, lgn/gpsm2
12/22/2011	US20110312893 Method for isolating neural cells with tenascin-r compounds
12/22/2011	US20110312892 Anxiolytic compositions containing alpha s1-casein-derived peptides
12/22/2011	US20110312887 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue
12/22/2011	US20110312881 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
12/22/2011	US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/22/2011	US20110312543 Expression Vectors Based on Modified Ribosomal Protein Promoters and Uses Thereof in Post-Transcriptional Assessment
12/22/2011	US20110312514 Method For Determination And Quantification Of Radiation Or Genotoxin Exposure
12/22/2011	US20110312095 Method and constructs for increasing recombinant protein production in plants dehydration stress
12/22/2011	US20110312094 Use of double stranded rna to increase the efficiency of targeted gene alteration in plant protoplasts
12/22/2011	US20110312088 Cd19 binding agents and uses thereof
12/22/2011	US20110312086 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
12/22/2011	US20110312054 Isolation and Characterization of Schizochytrium Aggregatum Cellobiohydrolase I (CBH I)
12/22/2011	US20110312047 Polypeptides having C4 Dicarboxylic Acid Transporter Activity and Polynucleotides Encoding Same
12/22/2011	US20110312041 Dna polymerases with increased 3'-mismatch discrimination
12/22/2011	US20110312037 Dna polymerases with increased 3'-mismatch discrimination
12/22/2011	US20110312031 Trichoderma promoter
12/22/2011	US20110312030 Consistent high expression vector containing rep e mutated gene
12/22/2011	US20110312029 Novel regulatory elements
12/22/2011	US20110312028 Novel Lipolytic Enzyme ELIP
12/22/2011	US20110312026 Process for the production of riboflavin
12/22/2011	US20110312025 Improved production of riboflavin
12/22/2011	US20110312001 Compendium of ready-built stem cell models for interrogation of biological response
12/22/2011	US20110311985 Rnai based selection system
12/22/2011	US20110311693 Polypeptides having tyrosinase activity and polynucleotides encoding same
12/22/2011	US20110311679 Pregastric esterase and derivatives thereof
12/22/2011	US20110311615 Novel gp41 antigens
12/22/2011	US20110311587 Fusogenic virus-like particles and uses thereof
12/22/2011	US20110311582 Novel lipids and compositions for the delivery of therapeutics
12/22/2011	US20110311581 Reverse genetics of negative-strand rna viruses in yeast
12/22/2011	US20110311580 Settings for recombinant adenoviral-based vaccines
12/22/2011	US20110311573 Method for Preparing Recombinant Antigen Complex Using Rotavirus Nanoparticle
12/22/2011	US20110311569 HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof
12/22/2011	US20110311565 Phage Constructs, Sequences and Antigenic Compositions for Immunocontraception of Animals
12/22/2011	US20110311556 Anti-rhesus d monoclonal antibody
12/22/2011	US20110311552 Notch1 receptor binding agents and methods of use thereof
12/22/2011	US20110311551 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
12/22/2011	US20110311550 Agents for hcv treatment
12/22/2011	US20110311544 Anti-cd71 Monoclonal Antibodies and Uses Thereof for Treating Malignant Tumor Cells
12/22/2011	US20110311543 Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer
12/22/2011	US20110311542 Sp35 Antibodies and Uses Thereof
12/22/2011	US20110311541 Mutant proteins of the f protein of piv-5 and piv-2
12/22/2011	US20110311540 Wisp polypeptides and nucleic acids encoding same
12/22/2011	US20110311539 Diagnosis and treatment of cancer using cancer-testis antigens
12/22/2011	US20110311530 Truncated baff receptors
12/22/2011	US20110311523 Platelet derived growth factor receptor supports cytomegalovirus infectivity
12/22/2011	US20110311517 Antibodies and methods for treating estrogen receptor-associated diseases
12/22/2011	US20110311512 Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets
12/22/2011	US20110311506 Piggybac transposon variants and methods of use
12/22/2011	US20110311499 Secretion System and Methods for its Use
12/22/2011	US20110311494 Methods of reprogramming renal cells
12/22/2011	US20110311489 Optically-based stimulation of target cells and modifications thereto
12/22/2011	US20110311487 Delivery of therapeutic agents to the bone
12/22/2011	US20110311454 Molecules with extended half-lives, compositions and uses thereof
12/22/2011	US20110311449 Antibodies
12/22/2011	DE102008024282B4 Verfahren zur Vorhersage der Sekundärstruktur einer Nucleinsäuresequenz, Vorhersagevorrichtung für die Sekundärstruktur einer Nucleinsäuresequenz und Vorhersageprogramm zum Vorhersagen der Sekundärstruktur einer Nucleinsäuresequenz Method for predicting the secondary structure of a nucleic acid sequence predictor for secondary structure of nucleic acid sequence and prediction program for predicting the secondary structure of nucleic acid sequence
12/22/2011	CA2839421A1 Antibodies useful in passive influenza immuization
12/22/2011	CA2839420A1 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
12/22/2011	CA2802953A1 Methods of generating and screening for lytic chimeric polypeptides
12/22/2011	CA2802882A1 Methods and materials for assessing loss of heterozygosity
12/22/2011	CA2802857A1 Antibodies to endoplasmin and their use
12/22/2011	CA2802775A1 Increased protein expression through increased membrane formation
12/22/2011	CA2802726A1 Long lasting drug formulations
12/22/2011	CA2802599A1 Modified parvovirus having enhanced anti-tumour efficacy
12/22/2011	CA2802591A1 Animal models and therapeutic molecules
12/22/2011	CA2802376A1 Anti-vegf antibodies and uses thereof
12/22/2011	CA2802360A1 Nuclease activity of tal effector and foki fusion protein
12/22/2011	CA2802351A1 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures

1 ... 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 ... 4023